CG Oncology, Inc. (CGON)
72.59
-0.05
(-0.07%)
USD |
NASDAQ |
Nov 11, 16:00
72.59
0.00 (0.00%)
After-Hours: 19:01
CG Oncology Total Assets (Quarterly) : 1.047B for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 1.047B |
| June 30, 2026 | 1.086B |
| March 31, 2026 | 1.135B |
| December 31, 2025 | 791.59M |
| September 30, 2025 | 729.91M |
| June 30, 2025 | 701.44M |
| March 31, 2025 | 728.18M |
| December 31, 2024 | 754.80M |
| Date | Value |
|---|---|
| September 30, 2024 | 552.47M |
| June 30, 2024 | 564.33M |
| March 31, 2024 | 579.11M |
| December 31, 2023 | 199.30M |
| September 30, 2023 | 211.88M |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | 147.75M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
| Oncolytics Biotech, Inc. | 7.671M |
| Sangamo Therapeutics, Inc. | 59.96M |
| Sarepta Therapeutics, Inc. | 3.166B |
| Anixa Biosciences, Inc. | 15.07M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 55.70M |
| Shareholders Equity (Quarterly) | 990.97M |
| Debt to Equity Ratio | 0.0093 |
| Current Ratio | 21.70 |
| Net Debt Paydown Yield | -0.03% |